Enfermedades Infecciosas

Vicent, L; Goenaga, MA; Munoz, P; Marin-Arriaza, M; Valerio, M; Farinas, MC; Cobo-Belaustegui, M; de Alarcon, A; Rodriguez-Esteban, MA; Miro, JM; Goikoetxea-Agirre, AJ; Campos, DD; Garcia-Vazquez, E; Martinez-Selles, M; GAMEs Investigators.

Infective endocarditis in children and adolescents: a different profile with clinical implications

PEDIATRIC RESEARCH. 2022; 92(5): 1400-1406 Nº de citas: 10 [doi:10.1038/s41390-022-01959-3]

Diaz-Garcia, J; Gomez, A; Machado, M; Alcala, L; Reigadas, E; Sanchez-Carrillo, C; Perez-Ayala, A; De la Pedrosa, EGG; Gonzalez-Romo, F; Cuetara, MS; Garcia-Esteban, C; Quiles-Melero, I; Zurita, ND; Munoz-Algarra, M; Duran-Valle, MT; Sanchez-Garcia, A; Munoz, P; Escribano, P; Guinea, J.

Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(11): 3102-3109 Nº de citas: 22 [doi:10.1093/jac/dkac288]

Hernandez-Garcia, M; Garcia-Castillo, M; Melo-Cristino, J; Pinto, MF; Goncalves, E; Alves, V; Vieira, AR; Ramalheira, E; Sancho, L; Diogo, J; Ferreira, R; Cruz, H; Chaves, C; Bou, G; Cercenado, E; Delgado-Valverde, M; Oliver, A; Pitart, C; Rodriguez-Lozano, J; Tormo, N; Diaz-Reganon, J; Passaro, L; Duarte, J; Canton, R.

In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(11): 3163-3172 Nº de citas: 10 [doi:10.1093/jac/dkac298]

Escribano, P; Guinea, J.

Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena

Frontiers In Fungal Biology. 2022; 3: Nº de citas: 32 [doi:10.3389/ffunb.2022.1010782]

Santin, M; Perez-Recio, S; Grijota, MD; Anibarro, L; Barcala, JM; De Souza-Galvao, ML; Gijon, P; Luque, R; Sanchez, F.

Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)

PLoS One. 2022; 17(10): [doi:10.1371/journal.pone.0276387]

Infante, MS; Salmanton-Garcia, J; Fernandez-Cruz, A; Marchesi, F; Jaksic, O; Weinbergerova, B; Besson, C; Duarte, RF; Itri, F; Valkovic, T; Szotkovski, T; Busca, A; Guidetti, A; Glenthoj, A; Collins, GP; Bonuomo, V; Sili, U; Seval, GC; Machado, M; Cordoba, R; Blennow, O; Abu-Zeinah, G; Lamure, S; Kulasekararaj, A; Falces-Romero, I; Cattaneo, C; Van Doesum, J; Piukovics, K; Omrani, AS; Magliano, G; Ledoux, MP; de Ramon, C; Cabirta, A; Verga, L; Lopez-Garcia, A; Da Silva, MG; Stojanoski, Z; Meers, S; Lahmer, T; Martin-Perez, S; Davila-Vals, J; Van Praet, J; Samarkos, M; Bilgin, YM; Karlsson, LK; Batinic, J; Nordlander, A; Schonlein, M; Hoenigl, M; Racil, Z; Mladenovic, M; Hanakova, M; Zambrotta, GPM; De Jonge, N; Adzic-Vukicevic, T; Nunes-Rodrigues, R; Prezioso, L; Navratil, M; Marchetti, M; Cuccaro, A; Calbacho, M; Giordano, A; Cornely, OA; Hernandez-Rivas, JA; Pagano, L.

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

Frontiers in Oncology. 2022; 12: Nº de citas: 8 [doi:10.3389/fonc.2022.992137]

Alonso B; Pérez-Granda MJ; Latorre MC; Sánchez-Carrillo C; Bouza E; Muñoz P; Guembe M.

Production of biofilm by Staphylococcus aureus: Association with infective endocarditis?

Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2022; 40(8): 418-422 [doi:10.1016/j.eimce.2021.03.009]

González Del Castillo J; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; García-Botella A; García-Lledó A; Hernández-Sampelayo T; Gómez-Pavón J; Bouza E.

Lessons from COVID-19 for future disasters: an opinion paper

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(5): 444-454 Nº de citas: 1 [doi:10.37201/req/058.2022]

Cercenado E.

Rapid techniques for therapeutic optimization. Diagnostic stewardship

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35: 80-83 [doi:10.37201/req/s03.17.2022]

Gómez-Pavón J; González Del Castillo J; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; García-Botella A; García-Lledó A; Hernández-Sampelayo T; Bouza E.

COVID-19: Some unresolved issues

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(5): 421-434 Nº de citas: 2 [doi:10.37201/req/028.2022]

Sanchez-Somolinos, M; Diaz-Navarro, M; Benjumea, A; Tormo, M; Matas, J; Vaquero, J; Munoz, P; Sanz-Ruiz, P; Guembe, M.

Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study

Antibiotics-Basel. 2022; 11(10): Nº de citas: 5 [doi:10.3390/antibiotics11101300]

Aguilera-Alonso, D; Solis-Garcia, G; Noguera-Julian, A; Gonzalez-Martin, J; Cobena, AR; Baquero-Artigao, F; Rueda, CT; Rodriguez-Molino, P; Sanchez, IB; Vallmanya, T; Bernet-Sanchez, A; Domingo, LM; Rubio, A; Saavedra-Lozano, J; Ruiz-Serrano, MJ; Blazquez-Gamero, D; Lopez-Roa, P; Gomez-Pastrana, D; Prieto, MDL; Medina, EML; Gil-Brusola, A; Nalda, AM; Soriano-Arandes, A; Tortola, T; Falcon-Neyra, L; Galan, VG; Tebruegge, M; Santiago-Garcia, B.

Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

THORAX. 2022; 77(10): 1023-1029 Nº de citas: 9 [doi:10.1136/thorax-2021-218378]

Canada-Garcia, JE; Grippo, N; de Arellano, ER; Bautista, V; Lara, N; Navarro, AM; Cabezas, T; Martinez-Ramirez, NM; Garcia-Cobos, S; Calvo, J; Cercenado, E; Aracil, B; Perez-Vazquez, M; Oteo-Iglesias, J.

Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: Predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii

Frontiers in Microbiology. 2022; 13: Nº de citas: 5 [doi:10.3389/fmicb.2022.1000787]

Escribano, P; Gomez, A; Reigadas, E; Munoz, P; Guinea, J.

EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2022; 66(9): Nº de citas: 5 [doi:10.1128/aac.00849-22]

Pericas, JM; Llopis, J; Munoz, P; Gonzalez-Ramallo, V; Garcia-Leoni, ME; de Alarcon, A; Luque, R; Farinas, MC; Goenaga, MA; Hernandez-Meneses, M; Nicolas, D; Ramos-Martinez, A; Rodriguez-Esteban, MA; Villoslada-Gelabert, A; Miro, JM.

Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

Open Forum Infectious Diseases. 2022; 9(9): Nº de citas: 9 [doi:10.1093/ofid/ofac442]

Castellano M; Marín M; Alcalá L; Cunnas I; Rodríguez B; Ruíz MJ; Lasso J; Pérez-Cano R; Bouza E; Muñoz P; Guembe M.

Exhaustive diagnosis of breast implants with capsular contracture: The microbiology laboratory as a major support

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2022; 75(9): 3085-3093 Nº de citas: 3 [doi:10.1016/j.bjps.2022.06.014]

Butragueno-Laiseca, L; Marco-Arino, N; Troconiz, IF; Grau, S; Campillo, N; Garcia, X; Padilla, B; Fernandez, SN; Slocker, M; Santiago, MJ.

Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy

CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(9): Nº de citas: 6 [doi:10.1016/j.cmi.2022.03.031]

Escribano, P; Gomez, A; Reigadas, E; Munoz, P; Guinea, J; SPEIN Study Grp.

In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B

CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(9): Nº de citas: 7 [doi:10.1016/j.cmi.2022.05.013]